Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
157,184,610
-
Share change
-
+10,117,666
-
Total reported value
-
$2,478,904,357
-
Put/Call ratio
-
395%
-
Price per share
-
$15.77
-
Number of holders
-
145
-
Value change
-
+$150,604,537
-
Number of buys
-
73
-
Number of sells
-
64
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q3 2017
As of 30 Sep 2017,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
145 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
157,184,610 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, UBS ASSET MANAGEMENT AMERICAS INC, BROWN CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, and EcoR1 Capital, LLC.
This page lists
145
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.